Post-Genomic Design of Bioactive Molecules

Publisher： Bentham Science Publishers

E-ISSN： 1875-6697|1|2|147-162

ISSN： 1573-4099

Source： Current Computer - Aided Drug Design, Vol.1, Iss.2, 2005-04, pp. : 147-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging therapeutic targets in tuberculosis: post-genomic era

By Khasnobis Shampa   Escuyer Vincent E   Chatterjee Delphi  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 1, 2002-02 ,pp. : 21-40

Informa Healthcare

Access to resources Recommend Favorite

Proteomics - post-genomic cartography to understand gene function

By Naaby-Hansen S.   Waterfield M.D.   Cramer R.  

Trends in Pharmacological Sciences, Vol. 22, Iss. 7, 2001-07 ,pp. : 376-384

Elsevier

Access to resources Recommend Favorite

Identifying Biomarkers of Lung Cancer in the Post-Genomic Era

By  

Current Pharmacogenomics, Vol. 3, Iss. 4, 2005-12 ,pp. : 319-331

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Targets for Plasmodium falciparum: A Post-Genomic Review/Survey

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 2, 2006-02 ,pp. : 177-202

Bentham Science Publishers

Access to resources Recommend Favorite

Current Therapeutic Leads for the Treatment of Melanoma: Targeted Immunotherapy in the Post-genomic Era

By  

Current Molecular Pharmacology, Vol. 7, Iss. 1, 2014-04 ,pp. : 33-43

Bentham Science Publishers

Access to resources Recommend Favorite